William Blair analyst Brandon Vazquez reiterated an Outperform rating on Edwards Lifesciences (NYSE: EW).The analyst comments "Bottom Line: Sales and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE